These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17483473)

  • 1. In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection.
    Asquith B; Zhang Y; Mosley AJ; de Lara CM; Wallace DL; Worth A; Kaftantzi L; Meekings K; Griffin GE; Tanaka Y; Tough DF; Beverley PC; Taylor GP; Macallan DC; Bangham CR
    Proc Natl Acad Sci U S A; 2007 May; 104(19):8035-40. PubMed ID: 17483473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.
    Saito M; Braud VM; Goon P; Hanon E; Taylor GP; Saito A; Eiraku N; Tanaka Y; Usuku K; Weber JN; Osame M; Bangham CR
    Blood; 2003 Jul; 102(2):577-84. PubMed ID: 12560226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
    Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
    J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
    Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
    J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia/lymphoma virus type 1-infected patient with sporadic inclusion body myositis.
    Ozden S; Cochet M; Mikol J; Teixeira A; Gessain A; Pique C
    J Virol; 2004 Oct; 78(19):10320-7. PubMed ID: 15367598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.
    Kubota R; Nagai M; Kawanishi T; Osame M; Jacobson S
    AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1705-9. PubMed ID: 11080814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes.
    Hanon E; Hall S; Taylor GP; Saito M; Davis R; Tanaka Y; Usuku K; Osame M; Weber JN; Bangham CR
    Blood; 2000 Feb; 95(4):1386-92. PubMed ID: 10666215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Goon PK; Hanon E; Igakura T; Tanaka Y; Weber JN; Taylor GP; Bangham CR
    Blood; 2002 May; 99(9):3335-41. PubMed ID: 11964301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis.
    Parker CE; Daenke S; Nightingale S; Bangham CR
    Virology; 1992 Jun; 188(2):628-36. PubMed ID: 1374983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degenerate specificity of HTLV-1-specific CD8+ T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM/TSP).
    Kubota R; Furukawa Y; Izumo S; Usuku K; Osame M
    Blood; 2003 Apr; 101(8):3074-81. PubMed ID: 12480698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP).
    Yamano Y; Nagai M; Brennan M; Mora CA; Soldan SS; Tomaru U; Takenouchi N; Izumo S; Osame M; Jacobson S
    Blood; 2002 Jan; 99(1):88-94. PubMed ID: 11756157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease.
    Yamano Y; Cohen CJ; Takenouchi N; Yao K; Tomaru U; Li HC; Reiter Y; Jacobson S
    J Exp Med; 2004 May; 199(10):1367-77. PubMed ID: 15136590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of glutathione intracellular levels alters the spontaneous proliferation of lymphocyte from HTLV-1 infected patients.
    Novaes R; Freire-de-Lima CG; de Albuquerque RC; Affonso-Mitidieri OR; Espindola O; Lima MA; de Andrada Serpa MJ; Echevarria-Lima J
    Immunobiology; 2013 Sep; 218(9):1166-74. PubMed ID: 23669236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.
    Jacobson S; Shida H; McFarlin DE; Fauci AS; Koenig S
    Nature; 1990 Nov; 348(6298):245-8. PubMed ID: 2146511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
    Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
    J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state.
    Yasunaga Ji ; Sakai T; Nosaka K; Etoh Ki ; Tamiya S; Koga S; Mita S; Uchino M; Mitsuya H; Matsuoka M
    Blood; 2001 May; 97(10):3177-83. PubMed ID: 11342446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients.
    Greten TF; Slansky JE; Kubota R; Soldan SS; Jaffee EM; Leist TP; Pardoll DM; Jacobson S; Schneck JP
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7568-73. PubMed ID: 9636190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does HTLV-I persist despite a strong cell-mediated immune response?
    Asquith B; Bangham CR
    Trends Immunol; 2008 Jan; 29(1):4-11. PubMed ID: 18042431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.